1 October 2023 v2025.12.1 limited_company_frs_102_section_1a_v1_1_2 companies_houseSoftwarefalsetruetruetrueNo description of principal activityfalsetruexbrli:purexbrli:sharesiso4217:GBP092328392023-10-012024-09-30092328392024-09-30092328392023-09-3009232839core:WithinOneYear2024-09-3009232839core:WithinOneYear2023-09-3009232839core:ShareCapital2024-09-3009232839core:ShareCapital2023-09-3009232839core:RetainedEarningsAccumulatedLosses2024-09-3009232839core:RetainedEarningsAccumulatedLosses2023-09-3009232839bus:Director12023-10-012024-09-3009232839bus:RegisteredOffice2023-10-012024-09-3009232839core:PlantMachinery2023-10-012024-09-30092328392022-10-012023-09-3009232839core:PlantMachinery2024-09-3009232839core:PlantMachinery2023-10-0109232839core:PlantMachinery2023-09-300923283912023-10-012024-09-3009232839countries:EnglandWales2023-10-012024-09-3009232839bus:AuditExemptWithAccountantsReport2023-10-012024-09-3009232839bus:PrivateLimitedCompanyLtd2023-10-012024-09-3009232839bus:SmallEntities2023-10-012024-09-3009232839bus:FullAccounts2023-10-012024-09-30
Company registration number:
09232839
Expedite Health Limited
Unaudited Filleted Financial Statements for the year ended
30 September 2024
Expedite Health Limited
Statement of Financial Position
30 September 2024
20242023
Note££
Fixed assets    
Tangible assets 5
3,575
 
4,767
 
Current assets    
Debtors 6
92,738
 
64,336
 
Cash at bank and in hand
359,045
 
355,411
 
451,783
 
419,747
 
Creditors: amounts falling due within one year 7
(52,404
)
(48,938
)
Net current assets
399,379
 
370,809
 
Total assets less current liabilities 402,954   375,576  
Provisions for liabilities
(894
)
(1,192
)
Net assets
402,060
 
374,384
 
Capital and reserves    
Called up share capital
125
 
125
 
Profit and loss account
401,935
 
374,259
 
Shareholders funds
402,060
 
374,384
 
For the year ending
30 September 2024
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
28 February 2025
, and are signed on behalf of the board by:
Mr M L Mills
Director
Company registration number:
09232839
Expedite Health Limited
Notes to the Financial Statements
Year ended
30 September 2024

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
44 Kirkgate
,
Ripon
,
North Yorkshire
,
HG4 1PB
, United Kingdom.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Going concern

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.
Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Plant and machinery
25% reducing balance

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is more likely than not that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured on an undiscounted basis at the tax rates that would apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted at the statement of financial position date.

Provisions for liabilities

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.
Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

4 Average number of employees

The average number of persons employed by the company during the year was
3
(2023:
3.00
).

5 Tangible assets

Plant and machinery etc.
£
Cost  
At
1 October 2023
and
30 September 2024
20,960
 
Depreciation  
At
1 October 2023
16,193
 
Charge
1,192
 
At
30 September 2024
17,385
 
Carrying amount  
At
30 September 2024
3,575
 
At 30 September 2023
4,767
 

6 Debtors

20242023
££
Trade debtors
88,319
 
59,354
 
Other debtors
4,419
 
4,982
 
92,738
 
64,336
 

7 Creditors: amounts falling due within one year

20242023
££
Taxation and social security
47,491
 
41,298
 
Other creditors
4,913
 
7,640
 
52,404
 
48,938